Holen Sie sich die Stockscreener-App
606.50
1.73%
-10.65
Handel nachbörslich:
611.53
5.03
+0.83%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$617.15
Offen:
$612.86
24-Stunden-Volumen:
3.14M
Relative Volume:
1.81
Marktkapitalisierung:
$227.87B
Einnahmen:
$43.74B
Nettoeinkommen (Verlust:
$6.58B
KGV:
35.04
EPS:
17.3072
Netto-Cashflow:
$6.11B
1W Leistung:
+4.67%
1M Leistung:
+6.74%
6M Leistung:
+42.31%
1J Leistung:
+11.30%
1-Tages-Spanne:
$603.99
$623.36
1-Wochen-Bereich:
$577.00
$628.08
52-Wochen-Spanne:
$385.46
$628.08
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Can Thermo Fisher Scientific Inc. stock hit record highs againWeekly Stock Summary & AI Forecasted Stock Moves - ulpravda.ru
Thermo Fisher Scientific stock edges lower as TD Cowen lifts target and JPM conference nears - TechStock²
Why Thermo Fisher Scientific Inc. stock remains resilient2025 Sector Review & Verified Stock Trade Ideas - ulpravda.ru
$443.6 Bn Microtome Global Market Trends, Opportunities and - GlobeNewswire
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
How The Narrative Around Thermo Fisher Scientific (TMO) Is Shifting After Q3 And New Forecasts - Yahoo Finance
Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings - TechStock²
Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings - TechStock²
Thermo Fisher Scientific Builds Hub to Support Local Life Sciences Companies - PHILADELPHIA.Today
The Truth About Thermo Fisher Scientific (TMO): Quiet Lab Giant, Loud Stock Moves - AD HOC NEWS
Thermo Fisher launches obesity registry to track real-world treatment outcomes - drugdiscoverytrends.com
Strategy To YieldBoost Thermo Fisher Scientific To 3.1% Using Options - Nasdaq
Thermo Fisher Scientific (TMO) Valuation Check As New Obesity Registry And Key Updates Draw Investor Focus - Yahoo Finance
Thermo Fisher Scientific to Acquire Clario in $8.875 Billion Deal, Strengthening Digital Clinical Research Capabilities - eHealth Magazine
Bovine Serum Albumin Market to hit US$ 30.89 Billion by 2032 | Top - openPR.com
Thermo Scientific™ Orbitrap Exploris™ EFOX Mass Detector: Empowering every lab to protect what matters most - Innovation News Network
Is Thermo Fisher (TMO) Using Clario And Margin Focus To Quietly Redefine Its Pharma Toolkit? - simplywall.st
Thermo Fisher Scientific stock hits a 52-week high as Evercore lifts target and obesity registry launch draws focus - TechStock²
Thermo Fisher stock closes higher near 52-week high as January data, earnings loom - ts2.tech
Thermo Fisher Scientific Stock: Quiet Grind Higher Tests Investors’ Patience - AD HOC NEWS
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Finviz
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - pharmiweb.com
Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago - sharewise.com
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treat - PharmiWeb.com
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - BioSpace
What to expect from Thermo Fisher Scientific's next quarterly earnings report - MSN
Robeco Institutional Asset Management B.V. Buys 233,200 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
The Truth About Thermo Fisher Sci.: Why Wall Street Is Quietly Obsessing - AD HOC NEWS
Thermo Fisher Scientific: Quiet Rally Or Calm Before The Next Storm? - AD HOC NEWS
Thermo Fisher Scientific enrols first patient in the new PPD CorEvitas Alzheimer’s Disease Registry - Select Science
Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO - ts2.tech
Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week HighShould You Buy? - MarketBeat
Thermo Fisher Scientific stock reaches 52-week high at $610.97 By Investing.com - Investing.com Nigeria
Thermo Fisher Scientific stock reaches 52-week high at $610.97 - Investing.com
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus - TechStock²
Unpleasant Surprises Could Be In Store For Thermo Fisher Scientific Inc.'s (NYSE:TMO) Shares - simplywall.st
Thermo Fisher Scientific wins three R&D 100 Awards for innovations accelerating drug development - R&D World
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $650 From $610, Maintains Outperform Rating - MarketScreener
G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.
Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)? - Yahoo Finance
14,819 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Greystone Financial Group LLC - MarketBeat
Railway Pension Investments Ltd Increases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Clinical Trial Supplies Company Evaluation Report 2025: Market Led by Thermo Fisher Scientific, Sharp Services, and Parexel Through End-to-End Capabilities Span Packaging, Logistics, Trial ManagementResearchAndMarkets.com - FinancialContent
Cynosure Group LLC Sells 5,293 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
HD Automatic Colony Counter Market Is Going to Boom |• Thermo Fisher Scientific • Beckman Coulter - openPR.com
Thermo Fisher (TMO) stock closes higher into 2026 — what to watch before Jan. 29 earnings - ts2.tech
North Growth Management Ltd. Purchases 6,000 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by GAM Holding AG - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Thermo Fisher (TMO): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom - ts2.tech
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):